Category Archives: Events
By Pharm Exec | Published: June 17, 2014
A new report from GlobalData states that the increase of biosimilars will have a negative impact on the biologics market after 2019. The report cites patent expirations of branded biologics and regulatory clarification as reasons for the prediction that biosimilars will capture the market share after 2019.
By Guest Blogger | Published: May 28, 2014
By Melanie Sena, Pharmaceutical Technology. FDA, in partnership with other federal and international agencies, has taken action against websites that sell potentially dangerous, unapproved prescription drugs to US consumers. FDA and the US Customs and Border Protection (CBP) also conducted examinations at US-based international mail facilities, where many packages containing prescription drugs enter the US, […]
By Michael Christel | Published: May 1, 2014
In our final Q&A installment previewing next week’s iPharma2014 digital forum (May 8-9 in NYC), we spoke with Matthew Fanelli and John Kenyon of Time Inc.’s MNI Targeted Media Group, who will present on “Digital, Big Data, and the Point of Care—What You Need to Know to Improve Patient Communication.” Fanelli is senior VP, digital, […]
By Guest Blogger | Published: March 31, 2014
Peter Houston looks at the pharma marketing takeaways from last week’s Digital Innovation Summit.
By Pharm Exec | Published: March 28, 2014
Adrian van den Hoven, Director General of the European Generics Association (EGA), this week called for the removal of barriers to generic medicines across the European Union.